Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
Clinical trial NCT05123807 · RECRUITING
Trial details
- NCT number
- NCT05123807
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-07
- Primary completion
- 2027-02-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.